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V ocal process granuloma is a disease whose
etiopathogenesis is not well defined. Therefore, its clinical
and surgical treatment is not standardized and its
therapeutic results depend on the hospital where it is seen.
Aim: Aiming to characterize patients with vocal process
granuloma treated in our hospital, the therapeutic approach
used and clinical evolution. Material and method: We
performed a retrospective review of records. Results: We
found more male vocal process granuloma, except when
associated with laryngeal intubation. The most frequent
related etiopathogenic factor was laryngeal-pharynx reflux,
followed by laryngeal intubation and vocal abuse. Clinical
management with proton-pump inhibitor (PPI), topical
inhalant steroid and phonotherapy was enough for remission
on 48.6% of the patients. Surgery for removal of the
granuloma associated with clinical management was
effective in 90% of the events. Later recurrences (more
than one year) were noticed in five patients, suggesting
that associated etiopathogenic factors should be held for a
long time.
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INTRODUCTION
Vocal process granuloma is a nonspecific inflammatory
process formed by granulation tissue that occurs primarily
in the vocal process of arytenoid cartilage 1.
Etiopathogenesis of granuloma is still undetermined
and it is attributed to three predisposing factors: vocal abuse,
laryngo-pharyngeal reflux disease (RLF) and laryngeal
intubation. If none of these causes are found, it is considered
idiopathic. It is predominant in male subjects, except in cases
associated with laryngeal intubation, which has higher
incidence in female cases.
Treatment is initially clinical and surgery is indicated
in persistent cases. The type of clinical and surgical
treatment has not been standardized yet between different
services and, consequently, the therapeutic results are
variable.
The purpose of the present study was to characterize
patients with vocal process granuloma treated in our service,
to present a therapeutic protocol used and to assess the
clinical progression of these patients.
MATERIAL AND METHOD
We conducted a retrospective study in which we
reviewed the medical charts of all patients seen in the Group
of Voice, HCFMUSP, between May 1996 and May 2003, with
diagnosis of vocal process granuloma. We excluded all cases
of suspected malignancy and anterior commissure
granulomas or other regions of the vocal folds, such as the
postoperative cases of laryngeal microsurgery using laser
CO
2
.
Data concerning gender, age and main complaint of
the patients, key associated etiopathogenic factors, treatment
performed and progression were obtained from the medical
charts. All patients underwent videotelelaryngoscopy before
and after each treatment, with follow up that ranged from 3
to 55 months, mean of 15.2 ± 15.9 months.
The statistical methodology included chi-square test
and likelihood ratio to check the association between
categorical variables. We considered as significant values p
< 0.05.
RESULTS
We studied 55 patients with diagnosis of vocal fold
granuloma. Out of the total, 38 (69%) were male, 17 (31%)
were female. Ages in male patients ranged from 21 to 85
years, mean of 48.9 years ± 15.4 years, female subjects
ranged from 19 to 64 years, mean age of 40.4 years ± 14.0
years.
The main complaints of patients are presented in
Graph 1. The duration of complaints ranged from 20 days
to 24 months, mean duration of 4.5 ± 4.6 months.
As to etiopathogenic factors, 20 people reported
symptoms (hoarseness, globus pharyngeal, chronic cough,
throat clearing, odynophagia) and/or presented signs
(hyperemia and edema of arytenoid region, interarytenoid
pakidermia and subglottic edema) suggestive of RLF, 14
patients referred history of laryngeal intubation related with
onset of symptoms, 7 patients presented classical history of
vocal abuse (for some reason, they had used their voice
with louder intensity, inappropriately or had screamed), and
14 were considered of idiopathic cause. Table 1 shows the
main etiopathogenic factors identified and their distribution
by gender.
All patients were initially submitted to common
empirical clinical treatment, regardless of identified
Table 1. Key etiopathogenic factor and distribution by gender.
Gender
Etiopathogenic Factor Male Female
RLF (n = 20) 18 (90.0%) 2 (10.0%)
Intubation (n = 14) 6 (42.9%) 8 (57.1%)
Vocal abuse (n = 7) 4 (57.1%) 3 (42.9%)
Idiopathic (n = 14) 10 (71.4%) 4 (28.6%)
Table 2. Distribution of remissions after clinical treatment in
different etiopathogenesis.
Remission after clinical treatment
Etiopathogenic factor Yes No
RLF (n = 13) 6 (46.2%) 7 (53.8%)
Intubation (n = 9) 4 (44.4%) 5 (55.6%)
Vocal abuse (n = 5) 4 (80.0%) 1 (20.0%)
Idiopathic (n = 8) 3 (37.5%) 5 (62.5%)
Likelihood ratio: p = 0.459
Graph 1. Main complaint in patients with granuloma.
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etiopathogenic factors. The treatment was based on use of
proton pump inhibitors (normally omeprazole 20-40mg/
day), inhaled corticoids (normally beclomethasone 750µg/
day), and speech therapy (one session a week) for 2 to 4
months. Those that presented improvement of symptoms
and disappearance of granuloma were discharged. In those
that maintained the granuloma, surgical treatment was
indicated. Surgical treatment was conducted with removal
of granuloma (cold or CO
2
 laser) associated or not with type
A botulinium toxin (Botox) in the thyroarytenoid muscle, as
previously described 2. In the postoperative period, patients
were submitted to clinical treatment including the use of
antibiotics, proton pump inhibitor, inhaled corticosteroids,
and eventually, speech therapy to reduce the risk of
recurrence.
Out of 55 patients who were initially assessed, 20
(36.4%) abandoned treatment after the first visit. Among
the patients that did not carry on with clinical treatment, 14
(70%) were male and 6 (30%) were female. There was no
association between interruption of treatment and gender
(p = 0.912). We did not observe association between
interruption of treatment and etiopathogenic factor given
that among the patients that abandoned therapy 7 cases
(35%) were caused by RLF and 6 (30%) were idiopathic, 5
(25%) were caused by intubation and 2 (10%) by vocal
abuse (p = 0.928).
Thus, 35 patients aged between 19 and 76 years,
mean of 46.4 + 14.6 years, were reassessed after clinical
treatment, and 24 (68.6%) were male and 11 (31.4%) were
female. The identified etiopathogenic factor in 13 (37.1%)
of the cases was RLF, 9 (25.7%) had had laryngeal intubation,
5 (14.3%) vocal abuse and 8 (22.9%) were considered
idiopathic.
Out of 35 reassessed patients, 17 (48.6%) presented
remission of granuloma after clinical treatment. The
distribution of remissions in relation to identified
etiopathogenic factor may be seen in Table 2. As we could
observe, in 80% of the cases associated with vocal abuse,
there was remission as a result of clinical treatment.
Out of 18 patients that persisted with the lesion and
were submitted to surgical treatment, 16 (88.9%) presented
remission. Early recurrence (after 3 months) after surgery
was observed in 2 patients, both submitted to simple
excision, without application of Botox. The etiopathogenic
factors were RLF and idiopathic cause, respectively. They
were submitted to a new surgery with application of Botox,
presenting remission of the pathology (Table 3).
Five patients presented late recurrence after a period
of remission that ranged from 15 to 51 months, with mean
of 37.2 + 16.5 months, three in the same site as the initial
lesion, one contralateral to the primary lesion and one that
used to be bilateral was recurred as unilateral lesion. New
clinical treatment was performed and 80% (4) of the patients
reached remission of granuloma.
DISCUSSION
The etiopathogenesis of vocal fold granuloma remains
undetermined 3. It is an affection with higher incidence in
men, despite the fact that there is no clear explanation about
this fact. The frequency, however, is inverted when we
consider only the case of post-intubation granuloma, in which
women are more prevalent, as demonstrated in this study.
Considering the relation between intermembrane and
intercartilaginous portions (glottic portion) of the vocal fold
in men (adduction = 1.2) than in women (adduction = 1.0),
we may suggest that the female larynx is more susceptible
to traumas by laryngeal intubation in the posterior region 4.
The vocal process granuloma occurs in the
cartilaginous portion of the glottis, not interfering with the
membranous portion and thus, it does not normally lead to
dysphonia, except in cases of large volume lesions. The
main complaint of patients in our study was dysphonia. Given
that patients were seen in the Group of Voice of our hospital,
there may have been a bias in the selection of cases because
the referred patients had predominance of vocal symptoms.
Moreover, among the etiopathogenic factors of granuloma,
we can include RLF and vocal abuse, found in 37% and 13%
of our patients, respectively. These factors may lead to
dysphonia per se and may have contributed to our findings.
Posterior laryngeal aggressive factors are considered
to be predisposing factors in onset of granuloma 5,6. Acid
exposure of the pharynx is prevalent in cases of granuloma.
According to Ylitalo (2002), acid reflux on the pharynx
(detected by 24-hour pH meter) occurred in 17 out of 26
cases with granuloma (1 to 20 episodes per patient) and in
5 out of 19 controls (1 to 8 episodes per person). The duration
of reflux is short and predominant in the standing position.
As to post-intubation granulomas, there is no
correlation between time of intubation and occurrence of
Table 3. Follow up and progression of patients treated of vocal process granuloma.
Etiopathogenic factor Remission before surgical treatment Remission after surgical treatment Early recurrence
RLF (n = 13) 6 (46.2%) 6 (46.2%) 1 (7.6%)
Intubation (n = 9) 4 (44.4%) 5 (55.6%)  
Vocal abuse (n = 5) 4 (80.0%) 1 (20.0%)  
Idiopathic (n = 8) 3 (37.5%) 4 (50.0%) 1 (12.5%)
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granuloma. Upon assessing the larynx of post-orotracheal
intubation cases, Santos (1994) observed: laryngeal erythema
in 94%, ulceration in 76%, with resolution within 6 weeks.
Laryngeal granuloma was detected in 44% of the cases and
most granulomas (57%) were developed four weeks after
extubation 7.
Patients with vocal abuse present low pitch, monotone
voice, abuse of vocal fry, and hyperfunction, which would
lead to further trauma in the vocal processes during
phonation 8.
Clinical treatment of vocal process granuloma,
according to the literature, may include empirical
treatment for RLF, inhaled corticoids and speech therapy
6,9-11. As to control of RLF, treatment with proton pump
inhibitor (PPI) is more efficient than anti-histaminic H2 12.
Treatment with inhaled corticoids has good response in
granulomas, and it may be the first treatment before
surgical intervention 13. Speech therapy reduces
hyperfunction, elevates the pitch up to comfortable level
and increases the number of vocal inflections. These
measures reduce the aggression to the arytenoid vocal
process, allowing improvement of 46.7% of patients with
granuloma 5,6,8,11.
In our study, the advocated clinical treatment initially
used focused on empirically treat RLF and vocal abuse,
regardless of identified etiopathogenic factors. We decided to
follow this approach because many times these factors might
be associated and it is difficult to exclude the possibility of a
second factor being present in a specific patient. Thus, there
was the possibility of having a second factor present in the
patients. Therefore, even patients with granuloma associated
with laryngeal intubation were treated with PPI, topical
corticoids and speech therapy. Despite comprehensive
treatment, the index of cure was relatively low (about half of
the cases). The insistence in clinical treatment for longer periods
of time than four months could have improved our rates.
According to Koufman (1994), the resolution of granuloma
with clinical treatment may take as long as six to eight months.
When the granuloma is refractory to clinical treatment,
surgery is indicated 6,14,15. However, surgery should be
associated with clinical treatment also in the postoperative
period to reduce the risk of recurrence.
As to surgical treatment, we did not observe evident
differences between the groups, but we point out that 5
out of 5 patients (100%) operated of granuloma associated
with intubation presented remission of the lesion.
In past years, the use of Botox has been supporting
surgical treatment to reduce recurrences. The injection is
made in the thyroarytenoid muscle and works as (1) inhibitor
of hypertonicity; (2) strengthens antagonist muscles, and
(3) restore balance of forces 6,14,15.
As a result of the reduction of the adduction force of
the vocal fold by the action period of Botox, there is no
forced contact between vocal processes during phonation,
cough and throat clearing, allowing scaring of mucosa and
disappearance of granuloma.
Early recurrence (before 3 months of surgery) in our
study was below that reported in the literature 3,9,16. Only 2
patients that underwent surgical treatment without Botox
had recurrence of granuloma.
The cases of late recurrence (after one year) have been
rarely described in the literature. The follow up of these patients
for a more prolonged period of time showed that some patients
still present the same initial symptoms and there was re-onset
of granuloma. None of the cases was associated with post-
intubation granuloma. Out of 5 cases that presented late
recurrence, three reported RLF symptoms. In this period, they
had not used anti-reflux drugs. It is possible that by maintaining
the reflux disease out of control, there would be a new
granuloma. These data are still scarce and have to be properly
studied, but they suggest that patients with RLF that develop
vocal fold granuloma should be maintained under clinical
treatment for more prolonged periods of time.
A fact that attracted our attention in the study was that
about one third of the patients abandoned the follow up after
the first visit. In this visit, they were instructed about the nature
of the laryngeal lesion and submitted to the described clinical
treatment. It is possible that many of them have improved
their symptoms with treatment and then abandoned the follow
up. Giving up treatment after the first visit makes us wonder
whether we should instruct further the patient about the
importance of treatment, disappearance of granuloma and
differential diagnosis. The vocal fold process is conceptually
a benign lesion. However, differential diagnosis includes
malignant laryngeal lesions. Thus, in selected cases (such as
atypical location of lesions and progressive growth despite
treatment), we should make a biopsy to be absolutely sure
about the nature of the lesion 10. Luzar (2000), in a clinical
and histomorphological retrospective study of 149 biopsies
of laryngeal granulomas found simple hyperplasia in 65.8%
(98 patients), abnormal hyperplasia in 4.7% (7 patients),
atrophic epithelium in 16.1% (24 patients), and normal
squamous epithelium in 13.4% (20 patients).
CONCLUSION
In our sample, vocal process granuloma affected
mainly men, except for cases associated with laryngeal
intubation. The main etiopathogenic factor associated was
RLF, followed by laryngeal intubation and vocal abuse. Clinical
treatment was based on the use of proton pump inhibitor,
topical corticoid and speech therapy that presented efficacy
over the lesion in about half of the cases. Surgical treatment
associated with clinical treatment was effective in remission
of granuloma in about 90% of the cases. Late recurrences
(after one year of treatment) may occur, suggesting that
follow up and, possibly, control of etiopathogenic factors in
the long run are recommended for these patients.
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